Connected Drug Delivery Devices Market Outlook

Connected drug delivery devices refer to smart wireless electronic systems that are used for administrating various drugs. They are equipped with dose reminders, adherence trackers, sensors, and examining tools to provide instant feedback for personalized patient care.

The global connected drug delivery devices market reached a value of US$ 490.9 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 2,951.5 Million by 2027, exhibiting a CAGR of 35.6% during 2022-2027.

As a result, these devices are commonly used for treating and managing various diseases, such as diabetes, hepatitis C, hypertension, multiple sclerosis, and clinically isolated syndrome.

Request for a PDF sample of this report:

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Connected Drug Delivery Devices Market Trends:

The global market is primarily being driven by the growing importance of preventive care. Furthermore, connected drug delivery devices aid in reducing dosing errors improving, as well as patient adherence and outcomes, which, in turn, is fueling their demand. In addition, the widespread adoption of networked electronic health records (EHR) in hospitals and laboratories is stimulating the market growth.

Some of the other factors, including the rising preference for connected devices, the growing prevalence of chronic diseases, and the rising geriatric population, are projected to drive the market growth in the upcoming years.

Buy This Report Now:

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Competitive Landscape with Key Players:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

  • Adherium Ltd.
  • BioCorp Production
  • Cohero Health Inc. (AptarGroup Inc.)
  • Elcam Medical ACS. Ltd
  • Findair Sp. z o. o.
  • Merck KGaA
  • Phillips Medisize (Molex LLC)
  • Propeller Health (Resmed Inc.)
  • Teva Pharmaceutical Industries Ltd.
  • West Pharmaceutical Services Inc.

Key Market Segmentation:

The report has categorized the market based on product, end user and technology.

Breakup by Product:

  • Connected Sensors
    • Connected Inhaler Sensors
    • Connectable Injection Sensors
  • Integrated Connected Devices
    • Connected Inhalation Devices
    • Connected Injection Devices

Breakup by End User:

  • Hospitals and Healthcare Providers
  • Homecare

Breakup by Technology:

  • Bluetooth
  • NFC
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South Africa, Others)

Ask Analyst for Customization and Explore full report with TOC & List of Figures:

Key highlights of the report:                                                    

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:


30 N Gould St Ste R

Sheridan, WY 82801 USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800